From August 28 to September 1, the 21st Congress of the International Society for Burn Injuries (ISBI) was held at the Guadalajara Convention Center in Mexico. Guadalajara, Mexico's second-largest city, drew burn experts from around the world to discuss the future of burn treatment — the first ISBI congress to return to in-person format since the pandemic, showcasing the latest global research results, clinical treatment experience, and innovative technologies.
At the opening ceremony, ISBI Secretary-General Professor Ariel Miranda delivered remarks, noting that the past two years had been extraordinarily difficult for the world, yet all those devoted to the cause of burn care can overcome hard times together. ISBI President Dr. Greenhalgh emphasized that ISBI, as a leading international burn treatment organization, should promote global cooperation to comprehensively raise treatment standards — and gave heartfelt thanks to contributors, highlighting that the consistent support of pharmaceutical companies is an indispensable part of ISBI's progress. As the platinum sponsor of this and many previous congresses, MEBO Group has long been committed to growing with ISBI.
MEBO Group Chairman Kevin Xu and Antonio Yung, Chief Representative of the Sacramento-China Office, attended the congress. At the booth, they held cordial talks with ISBI Secretary-General Dr. Ariel Miranda on possible future project cooperation in Mexico, and held further in-depth discussions with Professor Tina Palmieri of the UC Davis Medical Center burn surgery department on future academic collaboration.
In the bustling exhibition hall, MEBO Group's creative booth stood out most: its clean form and graceful lines resembled a butterfly breaking from its cocoon — symbolizing regenerative medical technology bringing benefit to burn patients worldwide, freeing them from painful disease to emerge reborn. Attendees from around the world stopped to learn about MEBO's products, technology, and latest progress — including physicians already applying regenerative medical technology, and many newcomers eager to try it after witnessing its results.
Mexican doctors who had achieved good results with MEBO Moist Exposed Burn Ointment visited the booth to discuss local registration, sales, and promotion in Mexico. ISBI President Dr. Greenhalgh also stopped by to try the ointment and thank MEBO Group for its sustained support of ISBI. As ISBI's long-term partner, MEBO Group looks forward to broader and deeper cooperation in writing a new chapter for burn treatment worldwide.